Healthcare provider profile · identity verified

Kim E. Dougan, MD

Family Practice · SEATTLE, WA · NPI 1164683512

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	419	137
Levothyroxine Sodium	Levothyroxine Sodium	319	95
Losartan Potassium	Losartan Potassium	298	95
Amlodipine Besylate	Amlodipine Besylate	193	60
Gabapentin	Gabapentin	168	56
Lisinopril	Lisinopril	168	59
Albuterol Sulfate Hfa	Albuterol Sulfate	151	61
Alprazolam	Alprazolam	149	29
Rosuvastatin Calcium	Rosuvastatin Calcium	148	44
Tamsulosin Hcl	Tamsulosin Hcl	122	46
Hydrochlorothiazide	Hydrochlorothiazide	118	40
Metoprolol Succinate	Metoprolol Succinate	114	36
Oxycodone Hcl	Oxycodone Hcl	113	17
Eliquis	Apixaban	107	18
Tramadol Hcl	Tramadol Hcl	102	20
Montelukast Sodium	Montelukast Sodium	99	31
Alendronate Sodium	Alendronate Sodium	96	33
Omeprazole	Omeprazole	96	35
Ezetimibe	Ezetimibe	95	28
Metformin Hcl	Metformin Hcl	94	30
Finasteride	Finasteride	93	27
Xarelto	Rivaroxaban	84	13
Estradiol	Estradiol	83	30
Buspirone Hcl	Buspirone Hcl	78	19
Citalopram Hbr	Citalopram Hydrobromide	73	21
Zolpidem Tartrate	Zolpidem Tartrate	73	24
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	70	24
Pravastatin Sodium	Pravastatin Sodium	70	22
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	68	15
Simvastatin	Simvastatin	63	18
Celecoxib	Celecoxib	62	14
Sertraline Hcl	Sertraline Hcl	59	18
Allopurinol	Allopurinol	53	19
Fluoxetine Hcl	Fluoxetine Hcl	52	19
Trazodone Hcl	Trazodone Hcl	52	15
Carvedilol	Carvedilol	50	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	50	15
Diazepam	Diazepam	48	suppressed
Fluticasone Propionate	Fluticasone Propionate	48	21
Januvia	Sitagliptin Phosphate	46	suppressed
Clonazepam	Clonazepam	45	suppressed
Donepezil Hcl	Donepezil Hcl	44	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	44	16
Acyclovir	Acyclovir	43	15
Famotidine	Famotidine	43	14
Potassium Chloride	Potassium Chloride	43	14
Spiriva Handihaler	Tiotropium Bromide	43	suppressed
Mirtazapine	Mirtazapine	42	15
Jardiance	Empagliflozin	41	suppressed
Azithromycin	Azithromycin	40	35
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	40	suppressed
Warfarin Sodium	Warfarin Sodium	39	suppressed
Duloxetine Hcl	Duloxetine Hcl	38	suppressed
Fenofibrate	Fenofibrate	38	14
Amitriptyline Hcl	Amitriptyline Hcl	37	11
Metoprolol Tartrate	Metoprolol Tartrate	37	11
Propranolol Hcl	Propranolol Hcl	37	15
Azelastine Hcl	Azelastine Hcl	36	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	35	29
Bupropion Hcl Sr	Bupropion Hcl	35	13
Memantine Hcl	Memantine Hcl	34	suppressed
Valacyclovir	Valacyclovir Hcl	34	17
Clopidogrel	Clopidogrel Bisulfate	33	11
Paroxetine Hcl	Paroxetine Hcl	33	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	32	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	30	15
Irbesartan	Irbesartan	30	suppressed
Ondansetron Odt	Ondansetron	30	14
Prednisone	Prednisone	30	24
Triamcinolone Acetonide	Triamcinolone Acetonide	29	19
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	28	suppressed
Topiramate	Topiramate	28	suppressed
Bupropion Xl	Bupropion Hcl	27	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	26	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Liothyronine Sodium	Liothyronine Sodium	26	suppressed
Lorazepam	Lorazepam	26	13
Oxycontin	Oxycodone Hcl	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	25	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Spironolactone	Spironolactone	23	suppressed
Tizanidine Hcl	Tizanidine Hcl	23	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	22	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	22	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	17
Ozempic	Semaglutide	22	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	22	suppressed
Cephalexin	Cephalexin	21	20
Arnuity Ellipta	Fluticasone Furoate	20	suppressed
Atenolol	Atenolol	20	suppressed
Furosemide	Furosemide	20	12
Baclofen	Baclofen	19	suppressed
Glipizide	Glipizide	19	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	19	suppressed
Aripiprazole	Aripiprazole	18	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Torsemide	Torsemide	18	suppressed
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Clobetasol Propionate	Clobetasol Propionate	17	12
Diclofenac Sodium	Diclofenac Sodium	17	11
Lamotrigine	Lamotrigine	17	suppressed
Naproxen	Naproxen	16	suppressed
Nitroglycerin	Nitroglycerin	16	suppressed
Pregabalin	Pregabalin	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	14
Telmisartan	Telmisartan	15	suppressed
Colchicine	Colchicine	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Metronidazole	Metronidazole	14	suppressed
Raloxifene Hcl	Raloxifene Hcl	14	suppressed
Rizatriptan	Rizatriptan Benzoate	14	suppressed
Invokana	Canagliflozin	13	suppressed
Digoxin	Digoxin	12	suppressed
Linzess	Linaclotide	12	suppressed
Meloxicam	Meloxicam	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Repatha Syringe	Evolocumab	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Ursodiol	Ursodiol	12	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	11	suppressed
Restasis	Cyclosporine	11	suppressed
Trulicity	Dulaglutide	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error